GGrantIndex
Sort

51,593 grants matching hepatitis

Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines

$876,592
Roger Keith Reeves · Beth Israel Deaconess Medical Center · R01 · FY2019 · AI

Analysis and Modulation of Virus-Host Interaction in Infections of the Liver

$876,128
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity

$875,639
Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2021 · ES

Disordered Cellular Cholesterol Movement, Cell Death, and Multisystem Disease

$875,449
John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2010 · HL

Defining mechanisms of disease and repair in a viral model of multiple sclerosis

$875,447
Thomas E Lane · University Of California-Irvine · R35 · FY2022 · NS

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$875,428
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Immunology of Acute and Chronic Viral Hepatitis

$875,252
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Infections, immunity, and inflammation in cancer

$875,117
Eric A Engels · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Durability of HBV DNA Suppression in Cirrhotics After Stopping Therapy

$875,047
Harry Janssen · University Health Network · U01 · FY2013 · DK

Reduce Transmission Risks &Improve HCV Treatment Access

$875,003
Johns Hopkins University · R01 · FY2004 · DA

Data Coordinating Center for the Alcoholic Hepatitis Research Network

$875,000
Barry P. Katz · Indiana University Indianapolis · U24 · FY2018 · AA

The effects of orange juice compared with sugar-sweetened beverage on risk factors and metabolic processes associated with the development of cardiovascular disease and type 2 diabetes

$874,671
Kimber Lee Stanhope · University Of California At Davis · R01 · FY2021 · HL

AlcHepNet DCC UMMS

$874,531
Bruce A Barton · Univ Of Massachusetts Med Sch Worcester · U24 · FY2018 · AA

Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets

$874,451
Peter J Havel · University Of California At Davis · R01 · FY2017 · HL

Reagent Program for HIV and other Infectious Diseases

$874,178
Sujatha Rashid · American Type Culture Collection · N01 · FY2024 · AI

Defining mechanisms of disease and repair in a viral model of multiple sclerosis

$874,084
Thomas E Lane · University Of California-Irvine · R35 · FY2023 · NS

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$873,331
James L. Sorensen · University Of California, San Francisco · UG1 · FY2018 · DA

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$872,822
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Ethnicity and fat deposition in obesity-related disease in youth

$872,724
Vicente Gilsanze · University Of Southern California · P60 · FY2008 · MD

Alimentary Tract Lipids in Health and Disease

$872,462
Martin Conrad Carey · Brigham And Women'S Hospital · R37 · FY2010 · DK

Regulation of Liver by Nuclear Ca2+ Signaling

$872,313
Yale University · P01 · FY2001 · DK

NIDA Clinical Trials Network: Greater New York Node

$871,690
John P Rotrosen · New York University School Of Medicine · UG1 · FY2015 · DA

Investigation of management and disease manifestations of viral hepatitis

$871,687
Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Center for Interventional Oncology

$871,672
Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2020 · CA

Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis

$871,604
Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2014 · DK